BC
WST icon

Bayforest Capital’s West Pharmaceutical WST Stock Holding History

Bayforest Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.4K Sell
177
-123
-41% -$30.6K 0.05% 589
2025
Q4 		$82.5K Sell
300
-1,499
-83% -$410K 0.06% 511
2025
Q3 		$472K Buy
1,799
+1,274
+243% +$310K 0.22% 160
2025
Q2 		$115K Buy
525
+258
+97% +$55.2K 0.05% 454
2025
Q1 		$59.8K Sell
267
-39
-13% -$10.7K 0.03% 543
2024
Q4 		$100K Buy
+306
New +$96.3K 0.13% 310

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bayforest Capital's WST Position: Q1 2026 in Review

Bayforest Capital reduced its West Pharmaceutical (WST) stake by 41% in Q1 2026, selling an estimated $30.6K and leaving 177 shares worth $44.4K. The position accounts for 0.05% of the portfolio, ranked #589.

Bayforest Capital first reported a position in WST in Q4 2024 and has held it in 6 quarters since. The position peaked at $472K in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Bayforest Capital held 177 shares of West Pharmaceutical worth $44.4K as of Q1 2026.
  • Bayforest Capital sold 123 West Pharmaceutical shares in Q1 2026, an estimated $30.6K.
  • West Pharmaceutical made up 0.05% of Bayforest Capital's portfolio in Q1 2026, its #589 holding.
  • Bayforest Capital first reported a position in West Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Bayforest Capital's West Pharmaceutical position peaked at $472K in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.